ArticleMultiple sclerosis and related disorders2012

The CombiRx trial of combined therapy with interferon and glatiramer cetate in relapsing remitting MS: Design and baseline characteristics.

Jw Lindsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.